BZYR (Burzynski Research Institute) Cyclically Adjusted PS Ratio: (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Burzynski Research Institute Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Burzynski Research Institute  (OTCPK:BZYR) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Burzynski Research Institute Cyclically Adjusted PS Ratio Related Terms


Burzynski Research Institute Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Burzynski Research Institute's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Burzynski Research Institute Cyclically Adjusted PS Ratio Chart

Burzynski Research Institute Annual Data
Trend Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Burzynski Research Institute Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BZYR vs AGTX, EMMA, ATXI: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, Burzynski Research Institute's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Burzynski Research Institute Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Burzynski Research Institute's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Burzynski Research Institute's Cyclically Adjusted PS Ratio falls into.



Burzynski Research Institute Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Burzynski Research Institute's Cyclically Adjusted Revenue per Share for the quarter that ended in Nov. 2025 is calculated as:

For example, Burzynski Research Institute's adjusted Revenue per Share data for the three months ended in Nov. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Nov. 2025 (Change)*Current CPI (Nov. 2025)
=0/324.1220*324.1220
=0.000

Current CPI (Nov. 2025) = 324.1220.

Burzynski Research Institute Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201602 0.000 237.111 0.000
201605 0.000 240.229 0.000
201608 0.000 240.849 0.000
201611 0.000 241.353 0.000
201702 0.000 243.603 0.000
201705 0.000 244.733 0.000
201708 0.000 245.519 0.000
201711 0.000 246.669 0.000
201802 0.000 248.991 0.000
201805 0.000 251.588 0.000
201808 0.000 252.146 0.000
201811 0.000 252.038 0.000
201902 0.000 252.776 0.000
201905 0.000 256.092 0.000
201908 0.000 256.558 0.000
201911 0.000 257.208 0.000
202002 0.000 258.678 0.000
202005 0.000 256.394 0.000
202008 0.000 259.918 0.000
202011 0.000 260.229 0.000
202102 0.000 263.014 0.000
202105 0.000 269.195 0.000
202108 0.000 273.567 0.000
202111 0.000 277.948 0.000
202202 0.000 283.716 0.000
202205 0.000 292.296 0.000
202208 0.000 296.171 0.000
202211 0.000 297.711 0.000
202302 0.000 300.840 0.000
202305 0.000 304.127 0.000
202308 0.000 307.026 0.000
202311 0.000 307.051 0.000
202402 0.000 310.326 0.000
202405 0.000 314.069 0.000
202408 0.000 314.796 0.000
202411 0.000 315.493 0.000
202502 0.000 319.082 0.000
202505 0.000 321.465 0.000
202508 0.000 323.976 0.000
202511 0.000 324.122 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Burzynski Research Institute Business Description

Address 9432 Katy Freeway, Houston, TX, USA, 77055
Burzynski Research Institute Inc operates as a research and development facility of Antineoplaston drugs currently being tested for the use in the treatment of cancer, and provides consulting services.